BAX and acute myeloid leukemia: In the case of the pro-apoptotic marker, the expression levels of BAX in AMLpatients was not significantly different from normal subjects where 55.56% ofthe AML patients showed elevated expression rates of this marker (Figure 4A and Figure 5).